125317-39-7 | Vinorelbine Ditartrate

Packsize	Purity	Availability	Price	Discounted Price
5mg	95%(HPLC)	in stock	$79.00	$55.00
10mg	95%(HPLC)	in stock	$140.00	$98.00
25mg	95	in stock	$263.00	$184.00
50mg	95	in stock	$384.00	$269.00

Description

• Catalog Number: AI16502
• Chemical Name: Vinorelbine Ditartrate
• CAS Number: 125317-39-7
• Molecular Formula: C53H67N4O20
• Molecular Weight: 1080.1139
• MDL Number: MFCD12545773
• SMILES: OC(=O)C(C(C(=O)O)O)O.OC(=O)C(C(C(=O)O)O)O.COC(=O)[N]1(c2cc3c(cc2OC)N(C2C43CCN3C4C(CC)(C=CC3)C(C2(O)C(=O)OC)OC(=O)C)C)c2ccccc2C2=C1CCC1CN(C2)CC(=C1)CC

Computed Properties

• Complexity: 1820
• Covalently-Bonded Unit Count: 3
• Defined Atom Stereocenter Count: 12
• Heavy Atom Count: 77
• Hydrogen Bond Acceptor Count: 23
• Hydrogen Bond Donor Count: 10
• Rotatable Bond Count: 16

Literature

• A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.

  Lung cancer (Amsterdam, Netherlands) 20140401

• Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.

  Oral oncology 20121101

• A case of intimal sarcoma of the pulmonary artery successfully treated with chemotherapy.

  International journal of clinical oncology 20121001

• Overdose of Vinblastine in place of Vinorelbine during IGEV chemotherapy.

  Immunopharmacology and immunotoxicology 20121001

• Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE).

  European journal of cancer (Oxford, England : 1990) 20121001

• P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.

  Molecular pharmacology 20121001

• Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases.

  Cancer chemotherapy and pharmacology 20121001

• Effect analysis of chemoradiotherapy after operation in patients with stage III A non-small cell lung cancer.

  Asian Pacific journal of tropical medicine 20121001

• Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.

  Anticancer research 20121001

• The SUMO protease SENP1 is required for cohesion maintenance and mitotic arrest following spindle poison treatment.

  Biochemical and biophysical research communications 20120928

• [Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120920

• Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival.

  Medical oncology (Northwood, London, England) 20120901

• Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer.

  Clinical lung cancer 20120901

• Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion.

  Experimental biology and medicine (Maywood, N.J.) 20120901

• Developments in the treatment of early NSCLC: when to use chemotherapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120901

• Prophylactic treatment of local reactions to i.v. vinorelbine: a randomized study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120801

• Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.

  Anti-cancer drugs 20120801

• Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.

  Anti-cancer drugs 20120801

• Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.

  British journal of cancer 20120724

• Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.

  International journal of radiation oncology, biology, physics 20120715

• High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer.

  Breast cancer (Tokyo, Japan) 20120701

• Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis.

  Lung cancer (Amsterdam, Netherlands) 20120701

• The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?

  Breast cancer research and treatment 20120701

• Vinorelbine in cancer therapy.

  Current drug targets 20120701

• First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.

  Expert opinion on pharmacotherapy 20120701

• Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.

  Medical oncology (Northwood, London, England) 20120601

• BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.

  The Journal of pathology 20120601

• Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer.

  Journal of cancer research and clinical oncology 20120601

• Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.

  Clinical breast cancer 20120601

• [Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120520

• Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line.

  Molecular and cellular endocrinology 20120515

• A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120501

• A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer.

  Journal of surgical oncology 20120501

• Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.

  International journal of radiation oncology, biology, physics 20120501

• Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.

  Lung cancer (Amsterdam, Netherlands) 20120501

• Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells.

  Biochemical pharmacology 20120501

• Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120501

• An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.

  Cell cycle (Georgetown, Tex.) 20120501

• Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer.

  Acta oncologica (Stockholm, Sweden) 20120501

• Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).

  International journal of radiation oncology, biology, physics 20120401

• Oral vinorelbine in metastatic breast cancer: a review of current clinical trial results.

  Cancer treatment reviews 20120401

• Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.

  Oncology reports 20120401

• Vinorelbine-induced oxidative injury in human endothelial cells mediated by AMPK/PKC/NADPH/NF-κB pathways.

  Cell biochemistry and biophysics 20120401

• Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.

  Cellular oncology (Dordrecht) 20120401

• Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: a north central cancer treatment group trial.

  Clinical breast cancer 20120401

• Routine administration of a single dose of cisplatin ≥ 75 mg/m2 after short hydration in an outpatient lung-cancer clinic.

  Bulletin du cancer 20120401

• Efficacy of vinorelbine and zoledronate combination therapy against postoperative recurrence of lung cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20120401

• [Establishment of animal model of a human lung adenocarcinoma drug-resistant
cell line Anip973/NVB and investigation on mechanism of drug resistance].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20120320

• A case report of complete remission of pulmonary metastases from epithelioid sarcoma to navelbine chemotherapy.

  American journal of therapeutics 20120301

• Sulfosalicylate mediates improved vinorelbine loading into LUVs and antineoplastic effects.

  Journal of liposome research 20120301

• A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).

  Cancer chemotherapy and pharmacology 20120301

• A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.

  European journal of cancer (Oxford, England : 1990) 20120301

• Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120301

• [The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• [A case of recurrent breast cancer with brain metastases successfully treated with vinorelbine and anastrozole after multiple chemo-endocrine therapies].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• [Remarkable improvement in a patient with metastatic and locally advanced HER2-positive breast cancer treated with trastuzumab plus vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120301

• The microtubule poison vinorelbine kills cells independently of mitotic arrest and targets cells lacking the APC tumour suppressor more effectively.

  Journal of cell science 20120215

• Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.

  British journal of cancer 20120214

• Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

  British journal of cancer 20120214

• A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor.

  Investigational new drugs 20120201

• Randomized phase II study of carboplatin-paclitaxel or gemcitabine-vinorelbine in patients with advanced nonsmall cell lung cancer and a performance status of 2: West Japan Thoracic Oncology Group 0004.

  American journal of clinical oncology 20120201

• Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20120201

• Pemetrexed-induced lung toxicity: a case report.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20120201

• A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer.

  Journal of cancer research and clinical oncology 20120201

• Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials.

  Clinical breast cancer 20120201

• Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120201

• Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.

  Anticancer research 20120201

• Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.

  Cancer biotherapy & radiopharmaceuticals 20120201

• Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature.

  Urologic oncology 20120101

• Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.

  Acta oncologica (Stockholm, Sweden) 20120101

• First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120101

• A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20120101

• Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20120101

• Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101

• Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120101

• EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.

  The Lancet. Oncology 20120101

• Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.

  Anticancer research 20120101

• Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats.

  International journal of nanomedicine 20120101

• A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.

  Swiss medical weekly 20120101

• Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.

  PloS one 20120101

• Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.

  BMC medical genomics 20120101

• Triplet platinum-based combination sequential chemotherapy improves survival outcome and quality of life of advanced non-small cell lung cancer patients.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.

  Asian Pacific journal of cancer prevention : APJCP 20120101

• Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.

  Onkologie 20120101

• Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer.

  Tumori 20120101

• Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215

• SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner.

  Cancer research 20111215

• Comparison of cisplatin- and carboplatin-based third-generation chemotherapy in 1,014 Chinese patients with advanced non-small-cell lung cancer.

  Medical oncology (Northwood, London, England) 20111201

• A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer.

  Medical oncology (Northwood, London, England) 20111201

• Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.

  Cancer chemotherapy and pharmacology 20111201

• The predictive value of epidermal growth factor receptor expression for sensitivity to vinorelbine in breast cancer.

  Basic & clinical pharmacology & toxicology 20111201

• Effects of navelbine and docetaxel on gene expression in human lung cancer cell lines.

  Cell biochemistry and biophysics 20111201

• Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.

  International journal of molecular medicine 20111201

• A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111201

• Chemotherapy in elderly patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20111201

• Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer.

  Expert opinion on drug metabolism & toxicology 20111201

• A phase II study of lipoplatin (liposomal cisplatin)/vinorelbine combination in HER-2/neu-negative metastatic breast cancer.

  Clinical breast cancer 20111201

• [Influence of Shenfu Injection on the quality of life of lung cancer patients receiving chemotherapy].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111201

• Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trial.

  International journal of radiation oncology, biology, physics 20111101

• Phase I trial of metronomic oral vinorelbine in patients with advanced cancer.

  Cancer chemotherapy and pharmacology 20111101

• Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20111101

• Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.

  Cancer science 20111101

• SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer.

  Breast cancer research and treatment 20111101

• Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111101

• Unexpected high levels of vorinostat when combined with vinorelbine in patients with advanced cancer.

  Current clinical pharmacology 20111101

• [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20111101

• Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.

  Cancer letters 20111028

• Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20111001

• Mastoid recurrence after radiotherapy for nasopharyngeal carcinoma: two case studies.

  Head & neck 20111001

• Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial.

  Lung cancer (Amsterdam, Netherlands) 20111001

• Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.

  Journal of the American Academy of Dermatology 20111001

• Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review.

  The Lancet. Oncology 20111001

• Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20111001

• Epidermal growth factor receptor mutations are associated with docetaxel sensitivity in lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20111001

• Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer.

  Cancer immunology, immunotherapy : CII 20111001

• Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma.

  Cancer chemotherapy and pharmacology 20111001

• Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.

  Bulletin du cancer 20111001

• [A case of non-small-cell lung cancer in an older adult with complications responding to vinorelbine single agent].

  Gan to kagaku ryoho. Cancer & chemotherapy 20111001

• Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

  Lancet (London, England) 20110917

• Combination chemotherapy for older adults with advanced non-small-cell lung cancer.

  Lancet (London, England) 20110917

• Bystander effect of vinorelbine alters antitumor immune response.

  International journal of cancer 20110915

• Very high quantitative tumor HER2 content and outcome in early breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110901

• Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses.

  Cancer immunology, immunotherapy : CII 20110901

• Chemotherapy and targeted therapies for unresectable malignant mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20110901

• Cutaneous recall phenomenon with vinorelbine.

  The Annals of pharmacotherapy 20110901

• [Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].

  Revue des maladies respiratoires 20110901

• [Complete regression of eyeball metastasis secondary to non-small-cell lung cancer with Cisplatin and Vinorelbin therapy].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20110901

• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.

  Cancer 20110815

• Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.

  International journal of radiation oncology, biology, physics 20110801

• The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance status.

  Lung cancer (Amsterdam, Netherlands) 20110801

• Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20110801

• A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients.

  Acta oncologica (Stockholm, Sweden) 20110801

• Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.

  The Lancet. Oncology 20110801

• [Clinical investigation of weekly cisplatin and vinorelbine with concurrent radiation therapy for locally advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110801

• Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.

  International journal of pharmaceutics 20110729

• Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20110701

• Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

  Lung cancer (Amsterdam, Netherlands) 20110701

• Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.

  Breast cancer research and treatment 20110701

• Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.

  Journal of cancer research and clinical oncology 20110701

• A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer.

  Breast cancer (Tokyo, Japan) 20110701

• Efficacy and tolerability of vinorelbine in the cancer therapy.

  Current drug safety 20110701

• Evaluation of the efficacy, toxicity and safety of vinorelbine incorporated in a lipid emulsion.

  International journal of pharmaceutics 20110615

• A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.

  Cancer chemotherapy and pharmacology 20110601

• Gemcitabine and vinorelbine combination is effective in both as a salvage and mobilization regimen in relapsed or refractory Hodgkin lymphoma prior to ASCT.

  Annals of hematology 20110601

• Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy.

  Integrative cancer therapies 20110601

• Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan.

  Pharmacoepidemiology and drug safety 20110601

• Advanced right lung adenocarcinoma invading left atrium and left ventricle via right superior pulmonary vein and partially occluding mitral valve in diastole.

  European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20110601

• Dose escalation of once weekly oral vinorelbine concurrent with weekly split dose hypofractionated chest radiation for palliation of advanced non-small cell lung cancer: a phase I/II study.

  The American journal of the medical sciences 20110601

• [Pleomorphic carcinoma of the lung: a case report].

  Revue de pneumologie clinique 20110601

• [A radical resection of non-small cell lung cancer invading chest wall with ipsilateral axillary lymph node metastases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110601

• Neoadjuvant dose-dense gemcitabine plus docetaxel and vinorelbine plus epirubicin for operable breast cancer: improved prognosis in triple-negative tumors.

  Drugs in R&D 20110601

• Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines.

  Journal of chemotherapy (Florence, Italy) 20110601

• Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.

  Journal of medicinal chemistry 20110512

• Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.

  Cancer chemotherapy and pharmacology 20110501

• Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?

  Lung cancer (Amsterdam, Netherlands) 20110501

• Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110501

• [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20110501

• Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study.

  Clinical lung cancer 20110501

• Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.

  Investigational new drugs 20110401

• Sensitive measurement of vinorelbine in dog plasma by liquid chromatography-electrospray ionization tandem mass spectrometry utilizing transitions from double-charged precursor ions.

  Biomedical chromatography : BMC 20110401

• Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).

  Annals of oncology : official journal of the European Society for Medical Oncology 20110401

• Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.

  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 20110401

• [Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over].

  Presse medicale (Paris, France : 1983) 20110401

• Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20110401

• [Efficacy of vinorelbine in advanced and metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110401

• Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer.

  Journal of chemotherapy (Florence, Italy) 20110401

• Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.

  British journal of cancer 20110329

• Management of inflammatory breast cancer after neoadjuvant chemotherapy.

  International journal of radiation oncology, biology, physics 20110315

• Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315

• Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.

  International journal of radiation oncology, biology, physics 20110301

• A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110301

• Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer.

  Anti-cancer drugs 20110301

• Diffuse intrinsic brainstem tumor in an infant: a case of therapeutic efficacy with vinorelbine.

  Journal of pediatric hematology/oncology 20110301

• Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.

  Anticancer research 20110301

• Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

  Clinical lung cancer 20110301

• [Relationship between the protein expression of ERCC1, BRCA, β-tubulin and K-ras and the efficacy and prognosis in advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110301

• Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies.

  The Journal of pharmacy and pharmacology 20110301

• All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.

  Journal of controlled release : official journal of the Controlled Release Society 20110210

• Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.

  Journal of cancer research and clinical oncology 20110201

• Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.

  Lung cancer (Amsterdam, Netherlands) 20110201

• Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110201

• Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765).

  Breast cancer research and treatment 20110201

• Blistering of the hand in a breast cancer patient. Extravasation.

  The Netherlands journal of medicine 20110201

• Trastuzumab and vinorelbine in early stages of HER2-positive breast cancer.

  Journal of chemotherapy (Florence, Italy) 20110201

• Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120

• The effects of Gemcitabine and Vinorelbine on inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) distribution of MCF-7 breast cancer cells.

  Acta histochemica 20110101

• Biweekly vinorelbine and gemcitabine as second-line and beyond treatment in ovarian cancer.

  Cancer chemotherapy and pharmacology 20110101

• Treatment of skin injury due to vinorelbine extravasation using bFGF and rhGM-CSF: an experimental study in a murine model.

  Biological research for nursing 20110101

• Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101

• Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110101

• Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer.

  Breast cancer research and treatment 20110101

• Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.

  Anticancer research 20110101

• [A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)].

  Revue des maladies respiratoires 20110101

• Second-line combination chemotherapy with vinorelbine and capecitabine in patients with advanced breast cancer previously treated with anthracyclines and/or taxanes.

  Chemotherapy 20110101

• A case report of vinorelbine monotherapy-related acute bronchospasm and non-ST elevation acute coronary syndrome.

  Tennessee medicine : journal of the Tennessee Medical Association 20110101

• A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.

  Journal of experimental & clinical cancer research : CR 20110101

• A Cisplatin and vinorelbine (NP) regimen as a postoperative adjuvant chemotherapy for completely resected breast cancers in China: final results of a phase II clinical trial.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• [Concurrent versus sequential systemic chemotherapy and whole brain radiation therapy for brain matastases in non-small-cell lung cancer patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20110101

• Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance.

  Neoplasma 20110101

• Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20110101

• Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.

  Tumori 20110101

• [Preparation and physicochemical properties of vinorelbine liposomes].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20110101

• Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01).

  BMC cancer 20110101

• [Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine].

  Molekuliarnaia biologiia 20110101

• A phase I study of UFT-oral vinorelbine in metastatic breast cancer.

  Oncology 20110101

• [Comparison of efficiency and toxicity of two chemotherapy protocols in treatment of advanced non-small cell lung cancer].

  Medicinski pregled 20110101

• Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity.

  Tumori 20110101

• Use of metronomic chemotherapy in oncology: results from a national Italian survey.

  Tumori 20110101

• Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers.

  Oncology 20110101

• Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.

  PloS one 20110101

• Which non-small-cell lung cancer patients achieve long-term survival?

  Indian journal of cancer 20110101

• Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol.

  Oncogene 20101209

• Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y.

  Journal of neuro-oncology 20101201

• High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

  Cancer investigation 20101201

• Successful salvage chemotherapy with gemcitabine and vinorelbine in a malignant pleural mesothelioma patient previously treated with pemetrexed.

  Japanese journal of clinical oncology 20101201

• Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.

  Gynecologic oncology 20101201

• Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.

  British journal of cancer 20101109

• Histology classification is not a predictor of clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with vinorelbine or gemcitabine combinations.

  Lung cancer (Amsterdam, Netherlands) 20101101

• Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.

  Annals of oncology : official journal of the European Society for Medical Oncology 20101101

• Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling.

  Molecular pharmacology 20101101

• Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.

  Breast cancer research and treatment 20101101

• Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report.

  Pediatric hematology and oncology 20101101

• Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.

  Oral oncology 20101101

• A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.

  Anticancer research 20101101

• [Antineoplastic drug-induced extravasation].

  Medizinische Klinik (Munich, Germany : 1983) 20101101

• Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101010

• Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.

  Investigational new drugs 20101001

• Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status.

  Critical reviews in oncology/hematology 20101001

• Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO).

  Critical reviews in oncology/hematology 20101001

• Prognostic significance of OCT4 expression in adenocarcinoma of the lung.

  Japanese journal of clinical oncology 20101001

• Personalizing therapy in an epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer using PF-00299804 and trastuzumab.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101001

• A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.

  Anticancer research 20101001

• [Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20101001

• ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100901

• Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100901

• The value of day 8 blood count in treatment decisions when using oral vinorelbine in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100901

• Breast cancer during pregnancy.

  Breast cancer research and treatment 20100901

• TLC and HPLC methods to follow the synthesis of vinorelbine.

  Journal of chromatographic science 20100901

• First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.

  Lung cancer (Amsterdam, Netherlands) 20100801

• Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?

  Cancer treatment reviews 20100801

• Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100801

• XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.

  Anti-cancer drugs 20100801

• Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801

• Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens.

  The Journal of thoracic and cardiovascular surgery 20100801

• A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100801

• Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer.

  Clinical breast cancer 20100801

• [Combined chemotherapy with cisplatin plus vinorelbine showed efficacy in a case of metastatic primary cutaneous adenoid cystic carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100801

• [Rituximab-mediated sensitization of B-NHL cell lines to apoptosis induced by gemcitabine and Navelbine in vitro].

  Zhongguo shi yan xue ye xue za zhi 20100801

• [Efficacy and safety of chemotherapy combined with interstitial (125)I seed implantation brachytherapy in unresectable stage IIIa/IIIb non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100801

• [Effect of sCD40L combined with vinorelbine on lung adenocarcinoma cell A549].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100720

• Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20100701

• Economic evaluation of docetaxel-gemcitabine versus vinorelbine-cisplatin combination as front-line treatment of patients with advanced/metastatic non-small-cell lung cancer in Greece: a cost-minimization analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100701

• Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.

  Breast cancer research and treatment 20100701

• Gemcitabine and other new cytotoxic drugs: will any find their way into primary therapy?

  Current hematologic malignancy reports 20100701

• Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite.

  Parasitology research 20100701

• Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100701

• Transitory, spontaneously recovering, peripheral facial nerve palsy after vionorelbine administration.

  La Tunisie medicale 20100701

• Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.

  Anticancer research 20100701

• Cytotoxic indole alkaloids from Melodinus tenuicaudatus.

  Journal of natural products 20100625

• Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.

  Breast cancer research and treatment 20100601

• Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?

  Lung cancer (Amsterdam, Netherlands) 20100601

• Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100601

• Phase II trial of single-agent oral vinorelbine in elderly (> or =70 years) patients with advanced non-small-cell lung cancer and poor performance status.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100601

• Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies.

  Breast (Edinburgh, Scotland) 20100601

• Fatal Clostridium difficile infection associated with vinorelbine chemotherapy: case report and literature review.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100601

• A case of rapidly growing pulmonary carcinosarcoma.

  International journal of clinical oncology 20100601

• [Malignant pilomatrixoma of head and neck. A case report].

  Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20100601

• [Postoperative adjuvant chemotherapy for lung, gastric, colorectal and breast cancers].

  Nihon rinsho. Japanese journal of clinical medicine 20100601

• Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer.

  Anticancer research 20100601

• Development of pegylated liposomal vinorelbine formulation using 'post-insertion' technology.

  International journal of pharmaceutics 20100531

• Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.

  Pediatric blood & cancer 20100501

• Polymeric micelles as a drug delivery system enhance cytotoxicity of vinorelbine through more intercellular accumulation.

  Drug delivery 20100501

• Vinorelbine for non-small cell lung cancer.

  Expert opinion on drug safety 20100501

• Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.

  Health technology assessment (Winchester, England) 20100501

• [Expression of hTERT mRNA in Anip973 and Anip973/NVB cell detected by quantitative real-time PCR].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100420

• Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy.

  American journal of clinical oncology 20100401

• Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer.

  Breast (Edinburgh, Scotland) 20100401

• [Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401

• [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20100401

• Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.

  International journal of radiation oncology, biology, physics 20100315

• VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma.

  Journal of cellular and molecular medicine 20100301

• Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.

  International journal of radiation oncology, biology, physics 20100301

• Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting.

  Internal medicine journal 20100301

• A phase II trial of induction gemcitabine and vinorelbine followed by concurrent vinorelbine and radiotherapy in locally advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20100301

• Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

  Cancer chemotherapy and pharmacology 20100301

• Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.

  Journal of cancer research and clinical oncology 20100301

• Inflammatory myofibroblastic tumor of the conjunctiva: response to chemotherapy with low-dose methotrexate and vinorelbine.

  Pediatric blood & cancer 20100301

• Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100301

• [Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100301

• [Treatment possibilities in breast cancer progressing after anthracyclines and/or taxanes].

  Magyar onkologia 20100301

• [Vinorelbine plus oxaliplatin versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: a systematic review].

  Zhongguo fei ai za zhi = Chinese journal of lung cancer 20100220

• Blockade of the extracellular signal-regulated kinase pathway enhances the therapeutic efficacy of microtubule-destabilizing agents in human tumor xenograft models.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20100215

• COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines.

  Lung cancer (Amsterdam, Netherlands) 20100201

• [Effects of MRI-assayed microvascular permeability on the accumulation of vinorelbine in xenograft tumors].

  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 20100201

• Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100201

• A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.

  British journal of cancer 20100105

• A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines.

  Journal of cancer research and clinical oncology 20100101

• Role of oxidative stress in vinorelbine-induced vascular endothelial cell injury.

  Free radical biology & medicine 20100101

• Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20100101

• Bilateral phrenic nerve paralysis as a manifestation of paraneoplastic syndrome.

  Acta oncologica (Stockholm, Sweden) 20100101

• Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100101

• Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic study.

  European journal of cancer (Oxford, England : 1990) 20100101

• Aggressive fibromatosis in children and adolescents: the Italian experience.

  Cancer 20100101

• [Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100101

• Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.

  BMC cancer 20100101

• A randomized controlled pilot trial of 'Feiji Recipe' on quality of life of non-small cell lung cancer patients.

  The American journal of Chinese medicine 20100101

• A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899.

  Journal of translational medicine 20100101

• A recall reaction and call for action.

  Onkologie 20100101

• Radiation recall with vinorelbine and cisplatin.

  Onkologie 20100101

• A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer.

  Hematology/oncology and stem cell therapy 20100101

• Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

  BMC cancer 20100101

• Long-term results of a pilot study on an intensive induction regimen for unresectable stage III non-small-cell lung cancer.

  Tumori 20100101

• Analysis of chemiotherapeutic protocols efficiency in therapy of advanced non small cell lung cancer.

  Medicinski arhiv 20100101

• Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer.

  Oncology 20100101

• Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.

  BMC cancer 20100101

• Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

  BMC cancer 20100101

• Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Chemotherapy 20100101

• Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies.

  Tumori 20100101

• Reinduction of hormone sensitivity to goserelin following chemotherapy with vinorelbine in castration-resistant prostate cancer.

  TheScientificWorldJournal 20100101

• Biweekly vinorelbine and gemcitabine as second-line treatment and beyond in non-small cell lung cancer.

  Chemotherapy 20100101

• Clinical comparison of safety and efficacy of vinorelbine/epirubicin (NE) with fluorouracil/epirubicin/cyclophosphamide (FEC).

  Asian Pacific journal of cancer prevention : APJCP 20100101

• Combination of oral vinorelbine and capecitabine in the treatment of metastatic breast cancer patients previously exposed to anthracyclines: a pilot study.

  Hematology/oncology and stem cell therapy 20100101

• Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia.

  Hematology/oncology and stem cell therapy 20100101

• An unusually large pleural mesothelioma with an outstanding clinical response and long lasting survival: a case report and literature review.

  Tumori 20100101

• Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.

  Pediatric blood & cancer 20091215

• The bioanalysis of vinorelbine and 4-O-deacetylvinorelbine in human and mouse plasma using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass-spectrometry.

  Biomedical chromatography : BMC 20091201

• Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• [Virchow's node as the form of onset of squamous cell carcinoma of the pancreas].

  Gastroenterologia y hepatologia 20091201

• Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091201

• Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091201

• Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20091201

• [Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism].

  Ai zheng = Aizheng = Chinese journal of cancer 20091201

• [A case of aggressive primary squamous cell carcinoma of the breast refractory to preoperative neoadjuvant chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• [A case of recurrent breast cancer responding to vinorelbine/trastuzumab combination therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20091201

• Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.

  Biochemical pharmacology 20091101

• Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.

  Oncology reports 20091101

• Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer.

  Clinical lung cancer 20091101

• Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091015

• Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.

  Cancer chemotherapy and pharmacology 20091001

• Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.

  Pediatric blood & cancer 20091001

• Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091001

• UFT plus oral folinic acid with alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.

  Onkologie 20091001

• Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090910

• International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.

  Journal of the National Cancer Institute 20090902

• A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090901

• Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20090901

• Rapid and sensitive LC-MS method for pharmacokinetic study of vinorelbine in rats.

  Biomedical chromatography : BMC 20090901

• Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone.

  Leukemia research 20090901

• Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases.

  The British journal of dermatology 20090901

• Capecitabine and vinorelbine in metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20090901

• Targeted therapies: Cetuximab plus chemotherapy in patients with advanced NSCLC.

  Nature reviews. Clinical oncology 20090901

• [A case of inflammatory carcinoma, well-controlled by chemotherapy, especially, vinorelbine, S-1 and trastuzumab].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090901

• Surgical vacuum-assisted closure for treatment of vinorelbine extravasation.

  Chinese journal of traumatology = Zhonghua chuang shang za zhi 20090801

• Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.

  Anticancer research 20090801

• Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model.

  Cancer biotherapy & radiopharmaceuticals 20090801

• All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.

  British journal of cancer 20090721

• MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.

  Acta oto-laryngologica 20090701

• Efficient mobilization of PBSC with vinorelbine/G-CSF in patients with malignant lymphoma.

  Bone marrow transplantation 20090701

• Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels.

  Neuropharmacology 20090701

• Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090701

• The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution.

  European journal of pharmacology 20090624

• Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601

• Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.

  Lung cancer (Amsterdam, Netherlands) 20090601

• Re: Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20090601

• A landmark point analysis with cytotoxic agents for advanced NSCLC.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090601

• Gemcitabine, vinorelbine, and Cisplatin in the treatment of advanced nonsmall cell lung cancer.

  American journal of clinical oncology 20090601

• Reciprocal effects of STAT5 and STAT3 in breast cancer.

  Molecular cancer research : MCR 20090601

• Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.

  Journal of natural products 20090601

• Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.

  Anticancer research 20090601

• The study of cisplatin and vinorelbine in metastatic uterine cervical cancer.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090601

• A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090515

• Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.

  Lancet (London, England) 20090502

• A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20090501

• Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.

  Lung cancer (Amsterdam, Netherlands) 20090501

• Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.

  Cancer 20090501

• Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in cisplatin-refractory germ cell tumor.

  Southern medical journal 20090501

• XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.

  Acta biochimica et biophysica Sinica 20090501

• Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastatic melanoma with poor prognosis.

  Anticancer research 20090501

• [Case of malignant pleural mesothelioma with long-term disease control after 4 different lines of systemic chemotherapy and pleurodesis].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090501

• Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

  Investigational new drugs 20090401

• Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20090401

• The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20090401

• Gefitinib in the treatment of advanced non-small-cell lung cancer.

  Expert review of anticancer therapy 20090401

• Future developments in the management of malignant pleural mesothelioma.

  Expert review of anticancer therapy 20090401

• Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy.

  International journal of clinical oncology 20090401

• [Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20090401

• [Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20090401

• Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090320

• [Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].

  Zhonghua yi xue za zhi 20090317

• Unilateral taxane-induced onychopathy in a patient with a brain metastasis.

  Dermatology online journal 20090315

• Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.

  International journal of radiation oncology, biology, physics 20090301

• Evaluation of the safety and compliance of 3-week cycles of vinorelbine on days 1 and 8 and cisplatin on day 1 as adjuvant chemotherapy in Japanese patients with completely resected pathological stage IB to IIIA non-small cell lung cancer: a retrospective study.

  Japanese journal of clinical oncology 20090301

• UFT plus vinorelbine in advanced non-small cell lung cancer: a phase I and an elderly patient-directed phase II study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090301

• Evaluation of potential interaction between vinorelbine and clarithromycin.

  The Annals of pharmacotherapy 20090301

• Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.

  Clinical lung cancer 20090301

• An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

  Lung cancer (Amsterdam, Netherlands) 20090201

• A two-faced young woman.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20090201

• Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.

  Onkologie 20090201

• Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.

  Anti-cancer drugs 20090201

• Chemotherapy-induced persistent serpentine supra-venous hyperpigmented eruption and persistent supra-venous erythematous eruption: case report.

  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 20090201

• [Chemotherapy for non-small cell lung cancer: split-dose administration of Cisplatin over four consecutive days and Vinorelbine ditartrate].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• [A case of metastatic breast cancer with liver metastasis effectively treated with capecitabine and vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20090201

• Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.

  Clinical breast cancer 20090201

• Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design.

  Clinical breast cancer 20090201

• Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors.

  Anticancer research 20090201

• A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.

  Anticancer research 20090201

• Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.

  Anticancer research 20090201

• Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

  British journal of cancer 20090113

• Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.

  Cancer letters 20090108

• Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.

  Journal of medicinal chemistry 20090108

• The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20090101

• Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine.

  The Journal of pharmacology and experimental therapeutics 20090101

• ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.

  Oncology reports 20090101

• A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer.

  PloS one 20090101

• Cisplatin-vinorelbine chemotherapy in non-small cell lung cancer is safe and well tolerated: results of a retrospective Hungarian clinical data analysis.

  Expert opinion on drug safety 20090101

• Chemotherapy and quality of life in NSCLC PS 2 patients.

  Acta oncologica (Stockholm, Sweden) 20090101

• Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.

  Oncology 20090101

• Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with chemotherapy.

  Oncology 20090101

• Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.

  The International journal of biological markers 20090101

• Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.

  International journal of medical sciences 20090101

• Management of elderly patients with advanced non-small cell lung cancer in Turkey.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.

  BMC cancer 20090101

• [Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis].

  Casopis lekaru ceskych 20090101

• Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma.

  Oncology 20090101

• Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer.

  Hematology/oncology and stem cell therapy 20090101

• Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma.

  Hematology/oncology and stem cell therapy 20090101

• Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas.

  Asian Pacific journal of cancer prevention : APJCP 20090101

• Inhibition of HER2/estrogen receptor cross-talk, probable relation to prolonged remission of stage IV breast cancer: a case report.

  Tumori 20090101

• Antiviral properties of antineoplastic drugs. From herpes simplex-1 disappearance to a wide antiviral action: a serendipity case report.

  Acta bio-medica : Atenei Parmensis 20090101

• [Atypical case of bronchus carcinoma].

  Praxis 20081203

• Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.

  Gynecologic oncology 20081201

• A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.

  Cancer 20081201

• Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.

  The Lancet. Oncology 20081201

• VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081201

• Long term follow-up of neoadjuvant-adjuvant combination treatment of IIIA stage non-small-cell-lung cancer: results of neoadjuvant carboplatin/vinorelbine and carboplatin/paclitaxel regimens combined with selective adjuvant chemotherapy according to in-vitro chemoresistance test.

  Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 20081201

• Treatment outcome in performance status 2 advanced NSCLC patients administered platinum-based combination chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20081101

• Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

  International journal of radiation oncology, biology, physics 20081101

• Multimodality treatment of mesenteric desmoid tumours.

  European journal of cancer (Oxford, England : 1990) 20081101

• A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer.

  Cancer 20081101

• Missing patient-reported outcome data in an adjuvant lung cancer study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081101

• Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081101

• Vinorelbine in breast cancer.

  Expert opinion on pharmacotherapy 20081101

• Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20081101

• Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081015

• Randomized cross-over study of patient preference for oral or intravenous vinorelbine in combination with carboplatin in the treatment of advanced NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20081001

• Effectiveness of third-generation chemotherapy on the survival of patients with advanced non-small cell lung cancer in Norway: a national study.

  Thorax 20081001

• HER-2-positive metastatic breast cancer: trastuzumab and beyond.

  Expert opinion on pharmacotherapy 20081001

• In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.

  Basic & clinical pharmacology & toxicology 20081001

• [Clinical effect of Vinorelbine monotherapy in 18 cases of advanced or metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081001

• [Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081001

• Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.

  Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20081001

• [DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20081001

• Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080910

• Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).

  Lung cancer (Amsterdam, Netherlands) 20080901

• Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: a prospective study.

  Lung cancer (Amsterdam, Netherlands) 20080901

• Epirubicin/vinorelbine adjuvant chemotherapy in young women with breast cancer is associated with preservation of menstrual function.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080901

• Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.

  The Annals of thoracic surgery 20080901

• Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901

• Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901

• A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971.

  Chronobiology international 20080901

• Weekly vinorelbine versus docetaxel for metastatic breast cancer after failing anthracycline treatment.

  Onkologie 20080901

• [Prevention of phlebitis caused by vinorelbine chemotherapy in outpatients with breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080901

• Pulmonary toxicity associated with vinorelbine-based chemotherapy in breast cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20080901

• [Analysis of cavitation of advanced NSCLC treated by rh-endostatin combined with NP chemotherapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080901

• MVP and vinorelbine for malignant pleural mesothelioma.

  Lancet (London, England) 20080823

• Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.

  Investigational new drugs 20080801

• A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.

  Lung cancer (Amsterdam, Netherlands) 20080801

• The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma.

  Leukemia 20080801

• Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

  Anti-cancer drugs 20080801

• [Efficacy and toxicity of trastuzumab combined vinorelbine in 21 patients with HER2 overexpressing metastatic breast cancer].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080801

• Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.

  Cancer 20080715

• Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.

  International journal of pharmaceutics 20080709

• Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.

  British journal of cancer 20080708

• A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.

  Journal of controlled release : official journal of the Controlled Release Society 20080702

• Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).

  Cancer chemotherapy and pharmacology 20080701

• Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.

  Cancer chemotherapy and pharmacology 20080701

• Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine.

  Cancer chemotherapy and pharmacology 20080701

• Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model.

  Nuclear medicine and biology 20080701

• A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080701

• [Bolus injection of vinorelbine reduces incidence of local venous toxicity in patients with non-small cell lung cancer and breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080701

• Phase I study of vinorelbine and irinotecan in previously untreated patients with advanced non-small cell lung cancer.

  Cancer chemotherapy and pharmacology 20080601

• Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial.

  Cancer chemotherapy and pharmacology 20080601

• Role of gemcitabine in metastatic breast cancer patients: a short review.

  Breast (Edinburgh, Scotland) 20080601

• Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients.

  Annals of hematology 20080601

• The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20080601

• Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.

  Lung cancer (Amsterdam, Netherlands) 20080601

• High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.

  Leukemia & lymphoma 20080601

• Inhibitors of tubulin polymerization: synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III.

  Bioorganic & medicinal chemistry 20080601

• A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080601

• Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080601

• Oral vinorelbine as first line chemotherapy in unfit elderly patients with hormone-refractory prostate cancer.

  Journal of chemotherapy (Florence, Italy) 20080601

• A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.

  Clinical breast cancer 20080601

• Metabolism pathway of vinorelbine (Navelbine) in human: characterisation of the metabolites by HPLC-MS/MS.

  Journal of pharmaceutical and biomedical analysis 20080512

• Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy during pregnancy. Review of cases reported.

  Lung cancer (Amsterdam, Netherlands) 20080501

• Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20080501

• Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080501

• Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

  Journal of the National Cancer Institute 20080416

• Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.

  Journal of the National Cancer Institute 20080416

• Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Emerging therapeutic options for breast cancer chemotherapy during pregnancy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080401

• Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.

  Breast (Edinburgh, Scotland) 20080401

• Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

  Cancer 20080401

• Bid truncation mediated by caspases-3 and -9 in vinorelbine-induced apoptosis.

  Apoptosis : an international journal on programmed cell death 20080401

• Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.

  Seminars in oncology 20080401

• A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

  Clinical breast cancer 20080401

• A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.

  Journal of neuro-oncology 20080301

• Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20080301

• Morphine in the treatment of incident pain triggered by vinorelbine infusion.

  Journal of pain and symptom management 20080301

• Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.

  Integrative cancer therapies 20080301

• Efficacy, toxicity and cost analysis for non-platinum triplet (gemcitabine and vinorelbine, followed by docetaxel) vs. platinum-based chemotherapy in IIIB/IV non-small-cell lung cancer: single-institution experience.

  European journal of cancer care 20080301

• Dose enhancement effect of anticaner drugs associated with increased temperature in vitro.

  Experimental oncology 20080301

• A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.

  International journal of pharmaceutics 20080204

• Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer.

  The Journal of laryngology and otology 20080201

• Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.

  Breast (Edinburgh, Scotland) 20080201

• Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.

  Investigational new drugs 20080201

• Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080201

• Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy.

  Respiratory medicine 20080201

• Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.

  Cancer chemotherapy and pharmacology 20080201

• [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].

  Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20080201

• Big question, small answer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080201

• Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080201

• MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.

  Respiration; international review of thoracic diseases 20080101

• Trastuzumab in pregnancy associated with poor fetal outcome.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Clinical outcome of stage III non-small-cell lung cancer patients after definitive radiotherapy.

  Lung 20080101

• Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080101

• [Combination of cisplatin and vinorelbine as adjuvant chemotherapy in non-small cell lung cancer patients--feasibility assessment of 5 consecutively treated patients].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080101

• Induction chemotherapy with cisplatin, vinorelbine, and mitomycin-C followed by surgery for patients with pathologic N2 non-small-cell lung cancer.

  Clinical lung cancer 20080101

• A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.

  Journal of veterinary internal medicine 20080101

• Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.

  BMC cancer 20080101

• Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer.

  Medical oncology (Northwood, London, England) 20080101

• [Use of radiochemotherapy for inoperable non-small cell lung cancer].

  Voprosy onkologii 20080101

• Erythema gyratum repens as the initial manifestation of lung cancer.

  European journal of dermatology : EJD 20080101

• Vinorelbine as first-line or second-line therapy for advanced breast cancer: a Phase I-II trial by the Danish Breast Cancer Co-operative Group.

  Acta oncologica (Stockholm, Sweden) 20080101

• Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC).

  Anticancer research 20080101

• Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status.

  Anticancer research 20080101

• Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.

  Acta oncologica (Stockholm, Sweden) 20080101

• Vinorelbine is effective for the malignant pleural effusion associated with lung cancer in mice.

  Anticancer research 20080101

• Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study.

  BMC cancer 20080101

• Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.

  International journal of medical sciences 20080101

• [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].

  Tumori 20080101

• Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature.

  In vivo (Athens, Greece) 20080101

• Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.

  Breast cancer research : BCR 20080101

• Trastuzumab and vinorelbine as highly effective and safe therapy for HER-2-overexpressing metastatic breast cancer. A single institution experience.

  Tumori 20080101

• Correlation between magnetic resonance imaging and histopathological tumor response after neoadjuvant chemotherapy in breast cancer.

  Tumori 20080101

• A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.

  Oncology 20080101

• Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.

  Anticancer research 20080101

• Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.

  Anticancer research 20080101

• Liposomal-encapsulated doxorubicin (Myocet; D-99) and vinorelbine in previously treated metastatic breast cancer patients: a feasibility study.

  Tumori 20080101

• A randomized study of gemcitabine plus cisplatin and vinorelbine plus cisplatin in patients with advanced non-small-cell lung cancer.

  Chang Gung medical journal 20080101

• Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer.

  Investigational new drugs 20071201

• Optimizing clinical care of patients with metastatic breast cancer: a new oral vinorelbine plus trastuzumab combination.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071201

• IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.

  Bone marrow transplantation 20071201

• The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action.

  Cancer research 20071201

• [Efficacy of adjuvant chemotherapy after left pneumonectomy on non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [A case undergoing repeated anaphylactic shock after systemic administration of vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071201

• Response to vinorelbine and low-dose cyclophosphamide chemotherapy in two patients with desmoplastic small round cell tumor.

  Pediatric blood & cancer 20071101

• Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim.

  Internal medicine journal 20071101

• Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).

  Anti-cancer drugs 20071101

• Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.

  British journal of cancer 20071022

• Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071010

• Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.

  European urology 20071001

• New treatment strategies in the management of hormone refractory prostate cancer (HRPC): only chemotherapy?

  European urology 20071001

• Adjuvant chemotherapy in non-small cell lung cancer -- how feasible is it in a non-trial population?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20071001

• Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.

  International journal of pharmaceutics 20071001

• Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20071001

• Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20071001

• Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20071001

• Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

  Molecular cancer therapeutics 20071001

• Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.

  Journal of chemotherapy (Florence, Italy) 20071001

• Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.

  Cancer 20070901

• Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070901

• A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070901

• Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070901

• Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by vinorelbine treatment of metastatic breast cancer.

  Onkologie 20070901

• [Analysis of factors associated with quality of life for patients with non-small lung cancer receiving outpatient vinorelbine therapy as alternative inpatient therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070901

• [Topical dimethyl sulfoxide and intralesional hyaluronidase administration for vinorelbine extravasation-induced rat skin injury].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20070901

• Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

  Clinical lung cancer 20070901

• Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.

  British journal of cancer 20070806

• Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study.

  Investigational new drugs 20070801

• A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus ifosfamide versus gemcitabine plus cisplatin in the treatment of chemo-naive patients with stages III and IV non-small cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20070801

• Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours.

  Cancer chemotherapy and pharmacology 20070801

• Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study.

  Cancer chemotherapy and pharmacology 20070801

• [Consideration of preventive free-flowing IV infusion method for vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• [Recent topics in surgical treatment of lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070801

• A review of the use of trastuzumab (Herceptin) plus vinorelbine in metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.

  Japanese journal of clinical oncology 20070701

• [Lung cancer treatment in elderly patients].

  Bulletin du cancer 20070701

• Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.

  British journal of cancer 20070604

• Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.

  Cancer chemotherapy and pharmacology 20070601

• Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: multicenter phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20070601

• A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.

  Lung cancer (Amsterdam, Netherlands) 20070601

• A case of hypersensitivity vasculitis after vinorelbine injection in a patient with metastatic breast cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20070601

• Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070601

• A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer.

  The Journal of urology 20070601

• Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070601

• Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070601

• Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.

  American journal of clinical oncology 20070601

• Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane.

  American journal of clinical oncology 20070601

• In vitro simulation study of individualized chemotherapy in lung cancer.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20070601

• A high performance liquid chromatography method for vinorelbine and 4-O-deacetyl vinorelbine: a decade of routine analysis in human blood.

  Journal of pharmaceutical and biomedical analysis 20070509

• Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study.

  Cancer chemotherapy and pharmacology 20070501

• Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer.

  Breast cancer research and treatment 20070501

• Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy.

  Cancer 20070501

• Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial.

  Cancer 20070501

• BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles.

  Cancer biology & therapy 20070501

• Role of induction chemotherapy in resectable N2 non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• Adjuvant chemotherapy for non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070501

• Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).

  Cancer research 20070501

• Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer.

  International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20070501

• A phase II study of single-agent oral vinorelbine in patients with pretreated advanced non-small-cell lung cancer.

  Clinical lung cancer 20070501

• Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070420

• Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.

  British journal of cancer 20070410

• Desmoplastic small round-cell tumor of the pancreas.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070410

• Single-agent chemotherapy for the treatment of elderly patients with advanced non-small-cell lung cancer: what is the best drug?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070410

• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

  Cancer chemotherapy and pharmacology 20070401

• Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.

  International journal of cancer 20070401

• A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma.

  Lung cancer (Amsterdam, Netherlands) 20070401

• Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.

  Cancer treatment reviews 20070401

• Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070401

• Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070401

• A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer.

  American journal of clinical oncology 20070401

• [Non-cisplatin based chemotherapy in advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• [Outpatient chemotherapy for lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• [Apoptotic mechanisms induced in breast cancer cells by vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070401

• Male breast cancer with mandibular metastasis. A case report.

  Minerva stomatologica 20070401

• [Strategy in the treatment of anthracycline-resistant breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401

• [Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070401

• Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070320

• Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.

  Journal of cancer research and clinical oncology 20070301

• In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070301

• Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.

  Lung cancer (Amsterdam, Netherlands) 20070301

• Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.

  Lung cancer (Amsterdam, Netherlands) 20070301

• Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.

  Cancer science 20070301

• Treatment options for patients with pretreated metastatic breast cancer.

  The Lancet. Oncology 20070301

• Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.

  The Lancet. Oncology 20070301

• A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20070301

• Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature.

  Clinical lung cancer 20070301

• Will single-time tumor profiling and a 'guilt by association' approach allow us to outsmart HER2-positive breast cancer?

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070215

• Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070215

• Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.

  Cancer chemotherapy and pharmacology 20070201

• Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

  American journal of hematology 20070201

• Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.

  Cancer chemotherapy and pharmacology 20070201

• Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): results of a prospective randomized study.

  Lung cancer (Amsterdam, Netherlands) 20070201

• Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070201

• Quality of life assessment in the TAX 326 study.

  Lung cancer (Amsterdam, Netherlands) 20070201

• Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070201

• [A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070201

• Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070201

• [A case of diaphragmatic paralysis caused by herpes zoster after anticancer chemotherapy].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070201

• Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• 6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20070101

• Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

  Haematologica 20070101

• Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20070101

• Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.

  BMC cancer 20070101

• Oral vinorelbine: role in the management of metastatic breast cancer.

  Drugs 20070101

• Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.

  Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20070101

• CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer.

  Acta oncologica (Stockholm, Sweden) 20070101

• Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer.

  Cancer journal (Sudbury, Mass.) 20070101

• Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocol.

  BMC cancer 20070101

• Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy.

  Acta oncologica (Stockholm, Sweden) 20070101

• Antiproliferative activity of methylated analogues of E- and Z-resveratrol.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20070101

• A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy.

  Respiratory research 20070101

• Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.

  BMC cancer 20070101

• Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.

  Drugs 20070101

• Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer.

  Anticancer research 20070101

• 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.

  Anticancer research 20070101

• Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.

  Chang Gung medical journal 20070101

• [Updates on gemcitabine on metastatic breast cancer].

  Bulletin du cancer 20070101

• Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer.

  BMC cancer 20070101

• A phase I dose-escalating and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer.

  Oncology 20070101

• Long-term survivors after chemotherapy in advanced non-small cell lung cancer.

  Anticancer research 20070101

• Chemotherapy-induced myelosuppression by vinorelbine: a comparison between different dose schedules by simulation.

  European review for medical and pharmacological sciences 20070101

• Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer.

  Tumori 20070101

• Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99).

  Oncology 20070101

• Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer.

  Oncology 20070101

• Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.

  Cancer 20061215

• Can similar oral blood exposures between studies result in a different bioavailability?

  Cancer chemotherapy and pharmacology 20061201

• Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.

  Cancer chemotherapy and pharmacology 20061201

• Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20061201

• Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061201

• Vinorelbine: friend or foe?

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20061201

• [Adjuvant chemotherapy for non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes.

  Clinical breast cancer 20061201

• [A case report of delay in switching from inpatient treatment to home-based care due to changes in pain and other symptoms following chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061201

• Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.

  The New Zealand medical journal 20061117

• A case of relapsing glioblastoma multiforme responding to vinorelbine.

  Journal of neuro-oncology 20061101

• Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.

  British journal of haematology 20061101

• Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20061101

• [A case of non-small cell lung cancer in which complete response was achieved with chemotherapy including cisplatin, vinorelbine, mitomycin C, followed by additional cisplatin, etoposide and concurrent radiotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20061101

• [Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer].

  Bulletin du cancer 20061101

• [The effect of amino acid nutritional support on serum tryptophan and melatonin in lung cancer patients receiving chemotherapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061101

• [Assessment of neoadjuvant chemotherapy in breast cancer patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061101

• Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer.

  British journal of cancer 20061023

• Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061015

• Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.

  British journal of cancer 20061009

• Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model.

  Lung cancer (Amsterdam, Netherlands) 20061001

• Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.

  International journal of radiation oncology, biology, physics 20061001

• The role of the anticancer drug vinorelbine in lipid bilayers using differential scanning calorimetry and molecular modeling.

  Chemistry and physics of lipids 20061001

• A phase II study of an oxaliplatin/vinorelbine/5-fluorouracil combination in patients with anthracycline-pretreated and taxane-pretreated metastatic breast cancer.

  Anti-cancer drugs 20061001

• Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer.

  Anti-cancer drugs 20061001

• Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

  Leukemia & lymphoma 20061001

• Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20061001

• [Circulating endothelial cells in the peripheral blood of advanced NSCLC patients].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20061001

• Docetaxel consolidation therapy following cisplatin, vinorelbine, and concurrent thoracic radiotherapy in patients with unresectable stage III non-small cell lung cancer.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20061001

• The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20060901

• Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.

  Cancer 20060901

• Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.

  European journal of cancer (Oxford, England : 1990) 20060901

• Oral vinorelbine may not induce acute pain at the tumor site.

  Journal of pain and symptom management 20060901

• Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

  The Lancet. Oncology 20060901

• Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20060801

• Systemic chemotherapy in the management of malignant peritoneal mesothelioma.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20060801

• Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).

  Lung cancer (Amsterdam, Netherlands) 20060801

• Common arm analysis: one approach to develop the basis for global standardization in clinical trials of non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.

  Lung cancer (Amsterdam, Netherlands) 20060801

• Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104.

  Cancer 20060801

• Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.

  Oncology reports 20060801

• Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060801

• [A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060801

• Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer.

  International journal of clinical oncology 20060801

• Sequential addition of an anthracycline-based regimen to docetaxel as neoadjuvant chemotherapy in patients with operable breast cancer.

  Clinical breast cancer 20060801

• [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• [Analysis of antineoplastic drugs used in Cancer Center, Sun Yat-sen University, during the period of 1996-2005].

  Ai zheng = Aizheng = Chinese journal of cancer 20060801

• [Correlation between the expression of PCDGF in serum and the chemotherapeutic sensitivity in NSCLC].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060801

• Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.

  International journal of cancer 20060715

• Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme.

  Cancer chemotherapy and pharmacology 20060701

• Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.

  Journal of neuro-oncology 20060701

• Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20060701

• Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?

  The Annals of thoracic surgery 20060701

• Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060701

• Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer.

  Journal of the Chinese Medical Association : JCMA 20060701

• Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060701

• Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate.

  Cancer 20060615

• Docetaxel induces apoptosis in hormone refractory prostate carcinomas during multiple treatment cycles.

  British journal of cancer 20060605

• The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.

  Cancer chemotherapy and pharmacology 20060601

• Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.

  Annals of hematology 20060601

• Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060601

• Predicting vinorelbine disposition and toxicity: does BSA provide more than a 'bad statistical association'?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• Treatment of metastatic breast cancer with vinorelbine and docetaxel.

  American journal of clinical oncology 20060601

• Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale).

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• [Chemotherapy for metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• [A case of multiple pyomyositis after chemotherapy for lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060601

• Intramedullary metastases due to non microcytic lung carcinoma.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060601

• Transitory, spontaneously recovering, peripheral facial nerve palsy after vinorelbine administration.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20060601

• [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20060601

• Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patients.

  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20060601

• Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopy.

  Journal of pharmaceutical and biomedical analysis 20060503

• Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: results of a prospective randomized phase II study.

  Investigational new drugs 20060501

• Oral vinorelbine alone or in combination with trastuzumab in advanced breast cancer: results from a pilot trial.

  Cancer chemotherapy and pharmacology 20060501

• A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20060501

• Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20060501

• [Lung carcinoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060501

• Non-platinum combination of gemcitabine in NSCLC.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Acute lung injury associated with vinorelbine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060420

• A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy.

  Cancer treatment reviews 20060401

• Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Triplet chemotherapy for malignant pericardial mesothelioma: a case report.

  Japanese journal of clinical oncology 20060401

• [Microsomal oxidative metabolism in the liver of rats treated with vinorelbine: evaluation through antipyrine elimination].

  Gastroenterologia y hepatologia 20060401

• Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.

  Onkologie 20060401

• A pilot trial of gemcitabine and vinorelbine plus capecitabine in locally advanced or metastatic nonsmall cell lung cancer.

  American journal of clinical oncology 20060401

• [A case of complete response in a primary lesion treated by gefitinib for two years after surgery of brain metastasis from lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060401

• [Clinical trials of vnorelbine in breast cancer--its scientific usefulness and development history until regulatory approval].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060401

• [Progress of medical and combined treatment for esophageal carcinoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20060401

• Successful treatment of intracardiac progression and metachronous multiple brain metastases from primary lung cancer.

  The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20060401

• [Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].

  Revue des maladies respiratoires 20060401

• [Extravasation of cytostatic agents: a serious complication of oncological treatment].

  Actas dermo-sifiliograficas 20060401

• [Analysis of genes related to sensitivity to navalbine and docetaxel in 10 lung cancer cell lines].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060401

• Something old, something new...

  Leukemia & lymphoma 20060401

• Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.

  Leukemia & lymphoma 20060301

• Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20060301

• Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.

  Lung cancer (Amsterdam, Netherlands) 20060301

• Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.

  Anti-cancer drugs 20060301

• [Advances in breast cancer chemotherapy].

  Nihon rinsho. Japanese journal of clinical medicine 20060301

• [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].

  Onkologie 20060301

• Nitroglycerin shows promise in lung cancer.

  The Lancet. Oncology 20060301

• [Palliative chemotherapy of head and neck cancer: present status and future development].

  Laryngo- rhino- otologie 20060301

• Chemotherapy of advanced non-small cell lung cancer in elderly patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060301

• [XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

• [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060301

• Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

  The New England journal of medicine 20060223

• Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060201

• Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.

  Clinical breast cancer 20060201

• Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.

  Clinical breast cancer 20060201

• [Maintenance chemotherapy in advanced NSCLC].

  Revue de pneumologie clinique 20060201

• Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060115

• Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention.

  Journal of controlled release : official journal of the Controlled Release Society 20060110

• Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).

  Lung cancer (Amsterdam, Netherlands) 20060101

• Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro.

  Oncology reports 20060101

• A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

  Oncology reports 20060101

• Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer.

  Oncology reports 20060101

• Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.

  Head & neck 20060101

• Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

  Breast cancer research : BCR 20060101

• Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Elevated CA125 level associated with Meigs' syndrome: case report and review of the literature.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.

  BMC cancer 20060101

• Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study.

  Anticancer research 20060101

• Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer.

  Anticancer research 20060101

• Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.

  Tumori 20060101

• Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.

  Anticancer research 20060101

• Pegylated liposomal doxorubicin and vinorelbine in recurrent ovarian carcinoma: a pharmacokinetic study on alternate administration sequences.

  Anticancer research 20060101

• Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.

  Breast cancer (Tokyo, Japan) 20060101

• A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.

  Cancer investigation 20060101

• Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.

  Anticancer research 20060101

• Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.

  Anticancer research 20060101

• Vinorelbine-based chemotherapy in hormone-refractory prostate cancer.

  Anticancer research 20060101

• Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients.

  Anticancer research 20060101

• Chemoimmunotherapy with low dose vinorelbine and interleukin-2 in treatment of patients with metastatic renal cell carcinoma.

  Neoplasma 20060101

• Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer.

  The oncologist 20060101

• Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).

  Anticancer research 20060101

• HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy.

  The oncologist 20060101

• A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.

  Oncology 20060101

• [Analysis of the treatment (neoadjuvant chemotherapy and surgery) in IIb and IIIa stages of non-small cell lung cancer].

  Pneumonologia i alergologia polska 20060101

• Genotoxic effects induced by fotemustine and vinorelbine in human lymphocytes.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20060101

• Short schedule of cisplatin and vinorelbine: a dose-finding study in non-small-cell lung cancer.

  Oncology 20060101

• A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.

  Oncology 20060101

• Symptoms in cancer patients and an unusual tumor: Case 3. Follicular dendritic cell sarcoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051220

• Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

  Cancer 20051215

• Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

  Cancer research 20051215

• The absolute bioavailability of oral vinorelbine in patients with solid tumors.

  Cancer chemotherapy and pharmacology 20051201

• Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination.

  Investigational new drugs 20051201

• [A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201

• [Preoperative induction chemotherapy for unresectable stage IIIA non-small-cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20051201

• Optimizing adjuvant chemotherapy in early-stage breast cancer.

  Oncology (Williston Park, N.Y.) 20051201

• Multiple cutaneous and uterine leiomyomas associated with gastric GIST.

  Journal of cutaneous medicine and surgery 20051201

• Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

  International journal of radiation oncology, biology, physics 20051115

• Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma, results of a phase II single center study.

  Annals of hematology 20051101

• Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051101

• Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.

  Cancer 20051101

• Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.

  Onkologie 20051101

• Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?

  Nature clinical practice. Oncology 20051101

• Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer.

  Chest 20051101

• [Effectiveness of 5-fluoruracil and vinorelbine in patients who had received multi-treatments for metastatic breast cancer].

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20051101

• The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.

  Lung cancer (Amsterdam, Netherlands) 20051001

• A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.

  Onkologie 20051001

• Characterization of human cytochrome P450 isoenzymes involved in the metabolism of vinorelbine.

  Fundamental & clinical pharmacology 20051001

• Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.

  Breast (Edinburgh, Scotland) 20051001

• Trastuzumab associated with successive cytotoxic therapies beyond disease progression in metastatic breast cancer.

  Clinical breast cancer 20051001

• Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.

  Clinical breast cancer 20051001

• A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC.

  British journal of cancer 20050919

• Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials.

  Lung cancer (Amsterdam, Netherlands) 20050901

• A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050901

• Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2).

  Annals of oncology : official journal of the European Society for Medical Oncology 20050901

• Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.

  Journal of cancer research and clinical oncology 20050901

• Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.

  Journal of cancer research and clinical oncology 20050901

• Phase I study of vinorelbine plus gemcitabine as third-line chemotherapy for refractory non-small cell lung cancer.

  Oncology reports 20050901

• Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.

  Journal of pharmaceutical and biomedical analysis 20050901

• Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Oral versus intravenous vinorelbine: clinical safety profile.

  Expert opinion on drug safety 20050901

• What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050901

• Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902.

  Clinical lung cancer 20050901

• Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.

  Clinical lung cancer 20050901

• Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours.

  Cancer chemotherapy and pharmacology 20050801

• A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer.

  Cancer chemotherapy and pharmacology 20050801

• Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• In vivo cryochemotherapy of a human lung cancer model.

  Cryobiology 20050801

• Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.

  European journal of haematology 20050801

• Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma.

  Japanese journal of clinical oncology 20050801

• The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer.

  Journal of evaluation in clinical practice 20050801

• Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20050801

• Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: a multicentre phase II study.

  Lung cancer (Amsterdam, Netherlands) 20050801

• Effects of navelbine and docetaxel on gene expression in lung cancer cell strains.

  Acta pharmacologica Sinica 20050801

• Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection.

  The Annals of thoracic surgery 20050801

• Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050801

• A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC).

  American journal of clinical oncology 20050801

• [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].

  Ai zheng = Aizheng = Chinese journal of cancer 20050801

• The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.

  Urology 20050801

• Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.

  International journal of clinical oncology 20050801

• [Efficacy of concurrent radio-chemotherapy and chemotherapy alone in the treatment of locally advanced non-small-cell lung cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050801

• Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease.

  Pediatric blood & cancer 20050701

• Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.

  Oncology reports 20050701

• Sequential therapy with Vinorelbine followed by Gemcitabine in patients with metastatic non small cell lung cancer (NSCLC), performance status (PS) 2, or elderly with comorbidities--a multicenter phase II trial.

  Lung cancer (Amsterdam, Netherlands) 20050701

• Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: pharmacoeconomic considerations.

  European journal of cancer (Oxford, England : 1990) 20050701

• Dexamethasone as a probe for vinorelbine clearance.

  British journal of clinical pharmacology 20050701

• Chemotherapy for non-small cell lung cancer in elderly patients.

  Chest 20050701

• [Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050701

• Bexarotene in combination with chemotherapy fails to prolong survival in patients with advanced non-small-cell lung cancer: results from the SPIRIT I and II trials.

  Clinical lung cancer 20050701

• Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.

  The New England journal of medicine 20050623

• Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.

  The New England journal of medicine 20050623

• Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway.

  Biochemical and biophysical research communications 20050617

• Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study.

  British journal of cancer 20050606

• Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.

  Lung cancer (Amsterdam, Netherlands) 20050601

• Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes.

  Japanese journal of clinical oncology 20050601

• A monoclonal antibody as an effective therapeutic agent in breast cancer: trastuzumab.

  Expert opinion on biological therapy 20050601

• [Postoperative adjuvant chemotherapy for non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [Chemotherapy for advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050601

• [Evaluation of combined chemotherapy with vinorelbine, ifosfamide and cisplatin in the treatment of metastatic non-small cell bronchial carcinoma].

  Revue des maladies respiratoires 20050601

• Vinorelbine and venous irritation: optimal parenteral administration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050601

• Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.

  Journal of controlled release : official journal of the Controlled Release Society 20050505

• Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050501

• Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity.

  Journal of pharmaceutical sciences 20050501

• Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.

  International journal of oncology 20050501

• Therapy of breast cancer with molecular targeting agents.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.

  Clinical lung cancer 20050501

• [Paralytic ileus due to vinorelbine].

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050501

• Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.

  Journal of the National Cancer Institute 20050406

• Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050401

• Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate.

  European urology 20050401

• Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20050401

• Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.

  The oncologist 20050401

• Docetaxel and vinorelbine plus GM-CSF in malignant melanoma.

  Oncology (Williston Park, N.Y.) 20050401

• Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.

  British journal of cancer 20050328

• A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).

  International journal of radiation oncology, biology, physics 20050315

• Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.

  Lung cancer (Amsterdam, Netherlands) 20050301

• Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC).

  Lung cancer (Amsterdam, Netherlands) 20050301

• Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050301

• Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.

  Molecular cancer therapeutics 20050301

• Tirapazamine with cisplatin and vinorelbine in patients with advanced non-small-cell lung cancer: a phase I/II study.

  Clinical lung cancer 20050301

• A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050301

• Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.

  British journal of cancer 20050227

• Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.

  Lung cancer (Amsterdam, Netherlands) 20050201

• Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.

  Lung cancer (Amsterdam, Netherlands) 20050201

• Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050201

• Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.

  Onkologie 20050201

• RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.

  Cancer research 20050201

• Liver metastases from breast cancer: management of patients with significant liver dysfunction.

  Cancer treatment reviews 20050201

• Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice.

  Cryobiology 20050201

• [A case of elderly non-small-cell lung cancer (NSCLC) treated in cooperation with a local hospital and with vinorelbine monotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050201

• Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.

  Cancer research 20050115

• A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.

  International journal of cancer 20050110

• Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study.

  Gynecologic oncology 20050101

• In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.

  Anti-cancer drugs 20050101

• Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer.

  Anti-cancer drugs 20050101

• Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.

  European journal of cancer (Oxford, England : 1990) 20050101

• Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050101

• Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.

  European journal of cancer (Oxford, England : 1990) 20050101

• Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.

  Breast cancer research and treatment 20050101

• [Second-line treatment for advanced non-small-cell lung cancers].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• Chemoresistance in non-small cell lung cancer.

  Current medicinal chemistry. Anti-cancer agents 20050101

• Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer.

  Lung 20050101

• Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.

  Anticancer research 20050101

• Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients.

  Anticancer research 20050101

• Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer.

  Anticancer research 20050101

• Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.

  Anticancer research 20050101

• Tubulin-targeting agents.

  Cancer chemotherapy and biological response modifiers 20050101

• Relationship between chemotherapy with paclitaxel, cisplatin, vinorelbine and titanocene dichloride and expression of proliferation markers and tumour suppressor gene p53 in human ovarian cancer xenografts in nude mice.

  European journal of gynaecological oncology 20050101

• [Chemotherapy of hormone-resistent cancer of the prostate].

  Urologiia (Moscow, Russia : 1999) 20050101

• Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer.

  Cancer investigation 20050101

• Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.

  Medical oncology (Northwood, London, England) 20050101

• Same-day pegfilgrastim and chemotherapy.

  Cancer investigation 20050101

• First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.

  Anticancer research 20050101

• Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20041201

• Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer.

  European urology 20041201

• Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.

  Gynecologic oncology 20041201

• Vinorelbine plus low-dose cisplatinum with concomitant radiotherapy for the treatment of locally advanced or inoperable non-metastasized non-small-cell lung cancer (stage I-IIIB): a phase II study.

  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20041201

• [A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041201

• Development of docetaxel in advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20041201

• Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.

  International journal of radiation oncology, biology, physics 20041115

• Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041115

• Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.

  European journal of cancer (Oxford, England : 1990) 20041101

• Chemotherapy for patients with hormone-refractory prostate cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041101

• Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041101

• [Do combinations without cisplatin represent an alternative to conventional chemotherapy in non-small cell lung cancers?].

  Revue de pneumologie clinique 20041101

• [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• Effect of antisense RNA targeting polo-like kinase 1 on cell cycle and proliferation in A549 cells.

  Chinese medical journal 20041101

• Overview of phase I/II pemetrexed studies.

  Oncology (Williston Park, N.Y.) 20041101

• Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.

  Lung cancer (Amsterdam, Netherlands) 20041001

• Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001).

  Lung cancer (Amsterdam, Netherlands) 20041001

• Vinorelbine and low-dose cyclophosphamide in the treatment of pediatric sarcomas: pilot study for the upcoming European Rhabdomyosarcoma Protocol.

  Cancer 20041001

• Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.

  Breast (Edinburgh, Scotland) 20041001

• Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041001

• Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

  The Annals of thoracic surgery 20041001

• Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trial.

  Clinical breast cancer 20041001

• [Two cases of recurrent lung cancer successfully treated with concurrent radiochemotherapy with vinorelbine plus cisplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041001

• Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.

  Cancer chemotherapy and pharmacology 20040901

• [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040901

• Treatment of advanced non-small-cell lung cancer in special populations.

  Oncology (Williston Park, N.Y.) 20040901

• [Evaluation of advanced non-small-cell lung cancer (ANSCLC) chemotherapy in routine practice].

  Revue des maladies respiratoires 20040901

• Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040815

• Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.

  British journal of cancer 20040802

• Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.

  Investigational new drugs 20040801

• A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040801

• Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

  Oncology reports 20040801

• Malignant mesothelioma--the UK experience.

  Lung cancer (Amsterdam, Netherlands) 20040801

• Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040801

• Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer.

  Cancer science 20040801

• [Predictive value of drug resistance-related genes expression in neoadjuvant chemotherapy in patients with non-small cell lung cancer of stage III].

  Ai zheng = Aizheng = Chinese journal of cancer 20040801

• Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.

  Journal of Korean medical science 20040801

• Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.

  Journal of chemotherapy (Florence, Italy) 20040801

• Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences.

  Pharmacy world & science : PWS 20040801

• Early-stage lung cancer findings end a debate, put focus on next steps.

  Journal of the National Cancer Institute 20040721

• Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.

  Lung cancer (Amsterdam, Netherlands) 20040701

• Severe myelotoxicity in a combination of gefitinib and vinorelbine.

  Lung cancer (Amsterdam, Netherlands) 20040701

• Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040701

• Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.

  The Laryngoscope 20040701

• Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040601

• Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer.

  American journal of clinical oncology 20040601

• Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer.

  American journal of clinical oncology 20040601

• Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.

  Clinical breast cancer 20040601

• Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules.

  Journal of experimental & clinical cancer research : CR 20040601

• Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.

  Journal of the National Cancer Institute 20040519

• Multidisciplinary management of lung cancer.

  The New England journal of medicine 20040506

• Phase II study of alternating chemotherapy regimens for advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20040501

• [Thymic carcinoma incidentally detected on routine chest computed tomography; report of a case].

  Kyobu geka. The Japanese journal of thoracic surgery 20040501

• [A pilot study of trastuzumab and vinorelbine-combined therapy for metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040501

• Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

  Japanese journal of clinical oncology 20040501

• A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.

  Cancer 20040415

• p53 N-terminal Ser-15 approximately P and Ser-20 approximately P levels in squamous cell lung cancer after radio/chemotherapy.

  American journal of respiratory cell and molecular biology 20040401

• High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.

  Japanese journal of clinical oncology 20040401

• Treatment of advanced non-small cell lung cancer with vinorelbine in elderly Thai patients.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20040401

• Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20040301

• Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents.

  Cancer biology & therapy 20040301

• Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.

  Gynecologic oncology 20040301

• Gemcitabine and vinorelbine as a salvage regimen for relapse in Hodgkin lymphoma after autologous hematopoietic stem cell transplantation.

  Pediatric hematology and oncology 20040301

• Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.

  Lung cancer (Amsterdam, Netherlands) 20040301

• [Docetaxel and non-small cell lung cancer].

  Bulletin du cancer 20040301

• Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer.

  Cancer chemotherapy and pharmacology 20040201

• In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells.

  Cancer chemotherapy and pharmacology 20040201

• Rationale for the use of gemcitabine in breast cancer (Review).

  International journal of oncology 20040201

• Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).

  Histochemistry and cell biology 20040201

• Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.

  Fundamental & clinical pharmacology 20040201

• Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.

  International journal of radiation oncology, biology, physics 20040201

• Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332.

  American journal of clinical oncology 20040201

• Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  Gynecologic oncology 20040201

• A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated.

  British journal of cancer 20040126

• Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

  The New England journal of medicine 20040122

• Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20040101

• Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908.

  Lung cancer (Amsterdam, Netherlands) 20040101

• Dramatic response of choroidal metastases from breast cancer to a combination of trastuzumab and vinorelbine.

  The breast journal 20040101

• Second line therapy with weekly low-dose docetaxel for pretreated non-small-cell lung carcinoma patients: a multicenter Italian phase II study.

  Lung 20040101

• Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics.

  Clinical lung cancer 20040101

• The impact of aging on chemotherapy.

  Clinical lung cancer 20040101

• Phase II trial of vinorelbine and estramustine in the treatment of metastatic hormone-resistant prostate cancer.

  Urologic oncology 20040101

• Mitoxantrone, vinorelbine and prednisone (MVD) in the treatment of metastatic hormonoresistant prostate cancer--a phase II trial.

  Prostate cancer and prostatic diseases 20040101

• [Medical therapy of elderly patients with advanced non-small cell lung carcinoma: significance and possibilities].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• [Rational and results of a scheduled sequential combination in advanced non-small cell lung carcinoma].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer.

  Cancer investigation 20040101

• A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer.

  Anti-cancer drugs 20040101

• Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

  Anticancer research 20040101

• Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.

  Acta oncologica (Stockholm, Sweden) 20040101

• Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel.

  Acta oncologica (Stockholm, Sweden) 20040101

• [Oxaliplatin].

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20040101

• Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

  The International journal of biological markers 20040101

• Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia.

  Journal of veterinary internal medicine 20040101

• A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine.

  Anticancer research 20040101

• Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).

  BMC cancer 20040101

• Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.

  Medical oncology (Northwood, London, England) 20040101

• Phase I study of Doxil and vinorelbine in patients with advanced malignancies.

  Cancer investigation 20040101

• Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer.

  Anticancer research 20040101

• Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

  Anticancer research 20040101

• Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: a phase I/II study.

  Oncology 20040101

• Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.

  European journal of gynaecological oncology 20040101

• Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.

  Cancer investigation 20040101

• A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.

  Anticancer research 20040101

• Cisplatin and vinorelbine remains a valid option for the front-line chemotherapy treatment of NSCLC.

  Anticancer research 20040101

• Adjuvant chemotherapy in resected non-small cell lung cancer.

  Rays 20040101

• Cisplatin and vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of experience.

  Le Journal medical libanais. The Lebanese medical journal 20040101

• Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study.

  Leukemia research 20031201

• Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

  European urology 20031201

• Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20031201

• Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.

  American journal of clinical oncology 20031201

• Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability.

  Breast cancer research and treatment 20031201

• Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.

  Oncology (Williston Park, N.Y.) 20031201

• Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.

  Oncology (Williston Park, N.Y.) 20031201

• Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.

  Journal of chemotherapy (Florence, Italy) 20031201

• [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study].

  Acta otorrinolaringologica espanola 20031201

• ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.

  International journal of cancer 20031110

• Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy.

  Cancer chemotherapy and pharmacology 20031101

• Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031101

• [Home chemotherapy for lung cancer: a five year retrospective study].

  Revue des maladies respiratoires 20031101

• [Chemotherapy for esophageal cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031101

• [Vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer previously treated with taxane-based chemotherapy].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101

• Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells.

  British journal of cancer 20031020

• A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia.

  Leukemia 20031001

• [Clinical observation of the efficacy of navelbine combined with ifosfamide and cisplatin in the treatment of advanced breast cancer].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001

• BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

  Cancer research 20031001

• Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.

  Japanese journal of clinical oncology 20031001

• Combination of trastuzumab and vinorelbine in metastatic breast cancer.

  Japanese journal of clinical oncology 20031001

• Supportive care in patients with advanced non-small-cell lung cancer.

  British journal of cancer 20030915

• Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

  Cancer 20030915

• Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2'-deoxyuridine (RP101).

  Cancer research 20030915

• Venous damage prevention by defibrotide in vinorelbine-treated patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20030901

• Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers.

  The American journal of pathology 20030901

• Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: a Spanish Lung Cancer Group phase III randomized trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901

• An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030901

• Trastuzumab/navelbine produces encouraging results in early breast cancer patients.

  Oncology (Williston Park, N.Y.) 20030901

• Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.

  Cancer chemotherapy and pharmacology 20030801

• Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer.

  Cancer chemotherapy and pharmacology 20030801

• Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

• Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.

  American journal of clinical oncology 20030801

• Combination of vinorelbine + doxorubicin in advanced breast cancer.

  Gan to kagaku ryoho. Cancer & chemotherapy 20030801

• Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study.

  Journal of chemotherapy (Florence, Italy) 20030801

• Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: a dose-finding study.

  Breast cancer research and treatment 20030801

• Combination chemotherapy with topotecan for non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030801

• [The role of surgical therapy for esophageal microcytoma. Experience of there clinical cases and results analysis].

  Minerva chirurgica 20030801

• Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.

  Cancer immunology, immunotherapy : CII 20030701

• Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030701

• [A case of recurrent lung cancer successfully treated with vinorelbine and cisplatin/carboplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030701

• Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.

  Cancer research 20030615

• Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

  Oncogene 20030605

• Fatal hepatic failure due to gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030601

• A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030601

• [Combination therapy with vinorelbine and gemcitabine in unresectable non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030601

• [Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030601

• A phase I study of capecitabine in combination with vinorelbine in advanced breast cancer.

  Clinical breast cancer 20030601

• Adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study.

  Breast (Edinburgh, Scotland) 20030601

• Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?

  Leukemia research 20030501

• Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030501

• Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030501

• Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.

  Lung cancer (Amsterdam, Netherlands) 20030501

• A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.

  Lung cancer (Amsterdam, Netherlands) 20030501

• The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.

  Molecular cancer therapeutics 20030501

• Vinorelbine and ischaemic colitis.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20030501

• Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines.

  British journal of cancer 20030422

• [Comparison of cisplatin combined with gemcitabine versus cisplatin combined with vinorelbine regimen for treatment of patients with advanced non-small cell lung cancer].

  Ai zheng = Aizheng = Chinese journal of cancer 20030401

• Biweekly docetaxel and vinorelbine in anthracycline-resistant metastatic breast cancer: a multicenter phase II study.

  American journal of clinical oncology 20030401

• Monotherapy options in the management of metastatic breast cancer.

  Seminars in oncology 20030401

• [Successful treatment with chemotherapy of vinorelbine and gemcitabine for an elderly patient with advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

  Cancer investigation 20030401

• Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.

  Clinical breast cancer 20030401

• The evolving role of capecitabine in breast cancer.

  Clinical breast cancer 20030401

• Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.

  Journal of the Chinese Medical Association : JCMA 20030401

• Chemotherapy for elderly patients with advanced non-small-cell lung cancer.

  Journal of the National Cancer Institute 20030305

• Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

  Journal of the National Cancer Institute 20030305

• The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.

  Breast cancer research and treatment 20030301

• [Cost-effectiveness of weekly paclitaxel for patients with advanced non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030301

• [Meningococcemia following chemotherapy for bronchial cancer].

  Presse medicale (Paris, France : 1983) 20030215

• Gemcitabine and vinorelbine followed by docetaxel in patients with advanced non-small-cell lung cancer: a multi-institutional phase II trial of nonplatinum sequential triplet combination chemotherapy (JMTO LC00-02).

  British journal of cancer 20030210

• Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030201

• Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.

  Lung cancer (Amsterdam, Netherlands) 20030201

• Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.

  Lung cancer (Amsterdam, Netherlands) 20030201

• Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20030201

• Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.

  Clinical breast cancer 20030201

• Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer.

  Cancer chemotherapy and pharmacology 20030201

• [Cost-effectiveness analysis: a reader's guide].

  Revue des maladies respiratoires 20030201

• Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group.

  Breast (Edinburgh, Scotland) 20030201

• Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.

  Oncology 20030101

• Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030101

• A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting.

  Anti-cancer drugs 20030101

• Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.

  Oncology 20030101

• Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer.

  Breast cancer research and treatment 20030101

• Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.

  Bone marrow transplantation 20030101

• Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.

  Cancer investigation 20030101

• Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma.

  Medical oncology (Northwood, London, England) 20030101

• Cutaneous drug reaction case reports: from the world literature.

  American journal of clinical dermatology 20030101

• Role of gemcitabine in the treatment of advanced and metastatic breast cancer.

  Oncology 20030101

• Vinorelbine and prednisone in older cancer patients with hormone-refractory metastatic prostate cancer. A phase II study.

  Tumori 20030101

• Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study.

  Oncology 20030101

• Population-based pharmacoeconomic model for adopting capecitabine/docetaxel combination treatment for anthracycline-pretreated metastatic breast cancer.

  The oncologist 20030101

• Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer.

  Oncology reports 20030101

• Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20030101

• Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

  Anticancer research 20030101

• Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.

  Anticancer research 20030101

• Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer.

  Acta oncologica (Stockholm, Sweden) 20030101

• The effect of rifampin on the pharmacokinetics of vinorelbine in the micropig.

  Anticancer research 20030101

• Vinorelbine, epirubicin and fluorouracil as first-line therapy in metastatic breast cancer--a phase II trial.

  Acta oncologica (Stockholm, Sweden) 20030101

• Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study.

  Anticancer research 20030101

• Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.

  Anticancer research 20030101

• Therapy increases poly-ADP-ribose and p53-Ser392-P levels in recurrent squamous cell lung cancer.

  Neoplasma 20030101

• Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.

  Cancer journal (Sudbury, Mass.) 20030101

• Quality of Life in elderly patients with cancer.

  Health and quality of life outcomes 20030101

• Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.

  Cancer investigation 20030101

• Antiblastic drug combinations with ifosfamide: an update.

  Oncology 20030101

• Ifosfamide in non-small cell lung cancer.

  Oncology 20030101

• Ifosfamide in advanced/disseminated breast cancer.

  Oncology 20030101

• Taxol plus gemcitabine and vinorelbine given every other week in advanced chemo-naïve non-small cell lung cancer patients.

  Oncology 20030101

• Alternating doublets: establishing the optimal multifractionated dosing schedule to administer docetaxel, cisplatin, gemcitabine, and vinorelbine in combination.

  Cancer investigation 20030101

• Acceptance of external infusion pumps in patients with advanced breast cancer receiving continuous infusion fluorouracil.

  Tumori 20030101

• Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study.

  British journal of cancer 20021202

• Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.

  Cancer chemotherapy and pharmacology 20021201

• GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021201

• A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

  Head & neck 20021201

• Two- versus three-drug combinations in the chemotherapy of advanced non-small-cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Second-line chemotherapy in relapsing or refractory patients with non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Chemotherapy of non-small cell lung cancer in the elderly.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC.

  Lung cancer (Amsterdam, Netherlands) 20021201

• Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.

  Cancer biotherapy & radiopharmaceuticals 20021201

• ZD0473 combined with other chemotherapeutic agents for the treatment of solid malignancies.

  European journal of cancer (Oxford, England : 1990) 20021201

• A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.

  The Korean journal of internal medicine 20021201

• Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure.

  British journal of cancer 20021118

• A phase II study of non-platinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20021101

• Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study.

  Breast cancer research and treatment 20021101

• Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021101

• A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021101

• [New data presented at ASCO 2002 concerning non-small cell bronchial cancers].

  Revue de pneumologie clinique 20021101

• [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].

  Revue de pneumologie clinique 20021101

• [Therapeutic strategies in advanced non-small cell bronchial cancers: platin-based combinations].

  Revue de pneumologie clinique 20021101

• Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015

• The effects of food on the pharmacokinetic profile of oral vinorelbine.

  Cancer chemotherapy and pharmacology 20021001

• Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.

  Lung cancer (Amsterdam, Netherlands) 20021001

• Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.

  European journal of clinical pharmacology 20021001

• Second-line chemotherapy with irinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: a phase II study.

  American journal of clinical oncology 20021001

• [A case of large-cell lung cancer with liver metastasis successfully treated using combination chemotherapy with CDDP and vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021001

• Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20021001

• Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.

  Cancer 20020915

• Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020915

• An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.

  Toxicology and applied pharmacology 20020915

• Selective deoxygenation of leurosine: concise access to anhydrovinblastine.

  The Journal of organic chemistry 20020906

• [Gemcitabine-based chemotherapy for non-small cell lung cancer (NSCLC)--a review of 30 randomized trials].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020901

• Skin necrosis from extravasation of vinorelbine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20020901

• The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).

  British journal of cancer 20020827

• Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogaster.

  Mutation research 20020826

• Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analyses.

  Biochemical pharmacology 20020815

• Re: Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

  Journal of the National Cancer Institute 20020807

• Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.

  The Journal of cardiovascular surgery 20020801

• Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.

  Lung cancer (Amsterdam, Netherlands) 20020801

• Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.

  European journal of cancer (Oxford, England : 1990) 20020801

• Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

  European journal of cancer (Oxford, England : 1990) 20020801

• Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies.

  American journal of clinical oncology 20020801

• Vinorelbine and paclitaxel for locoregional advanced or metastatic non-small-cell lung cancer.

  American journal of clinical oncology 20020801

• Chemotherapy of non-small cell lung cancer in elderly patients.

  Current medicinal chemistry 20020801

• Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.

  Cancer chemotherapy and pharmacology 20020801

• Effect of vinorelbine on the growth of human myeloma cell lines in vitro.

  Leukemia research 20020801

• Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer.

  Investigational new drugs 20020801

• Docetaxel/platinum combination provides quality-of-life advantage over vinorelbine/cisplatin in advanced lung cancer.

  Oncology (Williston Park, N.Y.) 20020801

• [Combinations of platinum salts and gemcitabine in the treatment of non-small-cell lung cancer].

  Bulletin du cancer 20020801

• [Platinum-free gemcitabine-based combinations: an alternative to conventional chemotherapy of non-small-cell lung cancers?].

  Bulletin du cancer 20020801

• [Gemcitabine and breast cancer].

  Bulletin du cancer 20020801

• [Gemicitabine in the treatment of epithelial ovarian cancer].

  Bulletin du cancer 20020801

• [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].

  Bulletin du cancer 20020801

• Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer.

  British journal of cancer 20020715

• The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.

  Cancer 20020715

• Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020701

• Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020701

• Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer.

  Current opinion in oncology 20020701

• In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.

  Breast cancer research and treatment 20020701

• Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.

  Anti-cancer drugs 20020701

• Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma.

  Cancer 20020615

• Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.

  Lung cancer (Amsterdam, Netherlands) 20020601

• First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020601

• Combination of vinorelbine, epirubicin, and cyclophosphamide as neoadjuvant chemotherapy for locally advanced breast cancer: phase II study.

  American journal of clinical oncology 20020601

• A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer.

  Anti-cancer drugs 20020601

• Trastuzumab/chemotherapy combinations in metastatic breast cancer.

  Seminars in oncology 20020601

• Gemcitabine and targeted therapy in metastatic breast cancer.

  Seminars in oncology 20020601

• Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer.

  Seminars in oncology 20020601

• ECCO 11 The European Cancer Conference: Lisbon, Portugal, October 21-25, 2001.

  Clinical prostate cancer 20020601

• [New drugs in bronchial cancer].

  Presse medicale (Paris, France : 1983) 20020511

• Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells.

  Cancer chemotherapy and pharmacology 20020501

• Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.

  British journal of clinical pharmacology 20020501

• A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020501

• Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020501

• Activity of vinorelbine in gastrointestinal cancers.

  Critical reviews in oncology/hematology 20020501

• Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

  Cancer chemotherapy and pharmacology 20020501

• Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.

  Clinical breast cancer 20020501

• Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• [Vinorelbine for non-small cell lung cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• [Gemcitabine].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• [Chemotherapy for elderly patients with lung cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20020501

• Vinorelbine in the treatment of non-small cell lung cancer.

  Current medicinal chemistry 20020401

• [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020401

• Epithelial ovarian cancer.

  Current treatment options in oncology 20020401

• Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.

  Breast cancer research and treatment 20020401

• Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy.

  British journal of cancer 20020318

• Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: excessive toxicity with a potentially active regimen.

  Gynecologic oncology 20020301

• Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20020301

• [Phase II study of combined Vinorelbine (Navelbine) plus cisplatin for advanced non-small cell lung cancer (an interim report)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020301

• [A case of recurrent lung cancer successfully treated using ambulatory chemotherapy with vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020301

• [An elderly patient with advanced non-small-cell lung cancer that responded remarkably to combination chemotherapy of vinorelbine and gemcitabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020301

• Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20020301

• A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020301

• Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial.

  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20020301

• Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

  Journal of the National Cancer Institute 20020220

• Chemotherapy for malignant mesothelioma: from doxorubicin to vinorelbine.

  Seminars in oncology 20020201

• Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.

  Seminars in oncology 20020201

• The role of gemcitabine-based doublets in the management of ovarian carcinoma.

  Seminars in oncology 20020201

• [Involvement of FAK, PI3-K and PKC in cell adhesion induced by microtubule disruption].

  Bulletin du cancer 20020201

• Clinical trials of new anticancer agents in recent years in China.

  Gan to kagaku ryoho. Cancer & chemotherapy 20020201

• [Developed new agents for lung cancer].

  Nihon Geka Gakkai zasshi 20020201

• Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.

  Investigational new drugs 20020201

• Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115

• Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients.

  Frontiers of radiation therapy and oncology 20020101

• Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.

  Thorax 20020101

• Vinorelbine in elderly patients with inoperable nonsmall cell lung carcinoma: a Phase II study.

  Cancer 20020101

• [Successful outpatient treatment with chemotherapy of weekly gemcitabine and vinorelbine for a patient with recurrent lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020101

• Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test.

  Oncology reports 20020101

• Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.

  Cancer investigation 20020101

• Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer.

  Cancer chemotherapy and pharmacology 20020101

• Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.

  Clinical breast cancer 20020101

• Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.

  Oncology 20020101

• Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice.

  Chronobiology international 20020101

• Breast cancer: single agents chemotherapy.

  Tumori 20020101

• Pharmacokinetics of Navelbine oral in elderly patients.

  Tumori 20020101

• In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.

  Anticancer research 20020101

• First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.

  Cancer investigation 20020101

• Effect of vinorelbine monotherapy in taxane-treated patients with advanced non-small-cell lung cancer.

  Medical oncology (Northwood, London, England) 20020101

• Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.

  The breast journal 20020101

• A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.

  The oncologist 20020101

• Pulmonary blastoma after liver transplant: a case report.

  Tumori 20020101

• The antineoplastic treatment in the elderly.

  La Clinica terapeutica 20020101

• A comparison of human G-Csf and human Gm-Csf given concurrently with anti-cancer chemotherapy.

  Oncology reports 20020101

• Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.

  Anticancer research 20020101

• Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.

  Oncology 20020101

• Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix.

  Oncology 20020101

• Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.

  Oncology 20020101

• Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

  Drugs & aging 20020101

• A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.

  Oncology 20020101

• Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.

  The oncologist 20020101

• Efficacy of a primary chemotherapy regimen combining vinorelbine, epirubicin, and methotrexate (VEM) as neoadjuvant treatment in 89 patients with operable breast cancer.

  The oncologist 20020101

• Oral cytotoxic drugs.

  I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 20020101

• Early detection and successful treatment of drug-induced pneumonitis with corticosteroids.

  Cancer investigation 20020101

• Moving forward with capecitabine: a glimpse of the future.

  The oncologist 20020101

• Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder.

  Urologic oncology 20020101

• Tumor sensitivity to anti-cancer drugs predicted by changes in fluorescence intensity and polarization in vitro.

  Anticancer research 20020101

• Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.

  Anticancer research 20020101

• Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.

  Anticancer research 20020101

• Phase II study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage III non-small cell lung cancer.

  Anticancer research 20020101

• The clinical effectiveness and cost-effectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation.

  Health technology assessment (Winchester, England) 20020101

• Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine.

  Critical reviews in oncology/hematology 20011201

• Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Radiosensitization with chemotherapeutic agents.

  Lung cancer (Amsterdam, Netherlands) 20011201

• Docetaxel combination produces 2-year survival advantage in NSCLC patients.

  Oncology (Williston Park, N.Y.) 20011201

• High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow.

  Bone marrow transplantation 20011201

• Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.

  Breast cancer research and treatment 20011201

• Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Oral vinorelbine: feasibility and safety profile.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC).

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.

  Japanese journal of clinical oncology 20011201

• Trials of new combinations of Herceptin in metastatic breast cancer.

  Anti-cancer drugs 20011201

• Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011101

• Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20011101

• Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).

  British journal of cancer 20011101

• Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells.

  British journal of cancer 20011101

• Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

  Cancer 20011101

• Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.

  Cancer 20011101

• Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma.

  Bone marrow transplantation 20011101

• Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• [Phase III clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001].

  Revue de pneumologie clinique 20011101

• [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].

  Revue de pneumologie clinique 20011101

• Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.

  Lung cancer (Amsterdam, Netherlands) 20011001

• Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.

  Lung cancer (Amsterdam, Netherlands) 20011001

• Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011001

• [Treatment outcomes with vinorelbine for metastatic breast cancer patients previously treated with both doxorubicin and docetaxel].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011001

• A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.

  Farmaco (Societa chimica italiana : 1989) 20011001

• A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Platinum compounds in the treatment of advanced breast cancer.

  Clinical breast cancer 20011001

• Commentary on 'A review of vinorelbine in the treatment of breast cancer'.

  Clinical breast cancer 20011001

• [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].

  Revue des maladies respiratoires 20010901

• Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial.

  BJU international 20010901

• Indications for chemotherapy in stage IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010901

• [Neo-adjuvant chemotherapy for breast cancer].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20010901

• Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma: a phase II multicenter trial.

  Cancer 20010815

• New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces.

  Journal of chromatography. A 20010810

• Treatment of vinorelbine-associated tumor pain.

  American journal of clinical oncology 20010801

• New cytotoxic agents and schedules for advanced breast cancer.

  Seminars in oncology 20010801

• Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.

  Internal medicine (Tokyo, Japan) 20010801

• Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.

  Gynecologic oncology 20010801

• [Vinorelbine in patients with malignant pleural mesothelioma--a phase II study].

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20010801

• Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

  Cancer chemotherapy and pharmacology 20010801

• [Clinical use of oxaliplatin in solid tumors].

  Bulletin du cancer 20010801

• Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010801

• Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine.

  Molecular pharmacology 20010701

• Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010701

• Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer.

  European journal of cancer (Oxford, England : 1990) 20010701

• Evaluating new treatments for advanced cancer.

  British journal of cancer 20010701

• A cost--utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer.

  Anti-cancer drugs 20010701

• High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.

  European journal of haematology. Supplementum 20010701

• Markedly diminished drug resistance-inducing properties of vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro.

  Cancer chemotherapy and pharmacology 20010701

• Rationale for non-platinum chemotherapy in advanced NSCLC.

  Oncology (Williston Park, N.Y.) 20010701

• Recent advances in the chemotherapy of non-small cell lung cancer.

  Japanese journal of clinical oncology 20010701

• Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010701

• A review of vinorelbine in the treatment of breast cancer.

  Clinical breast cancer 20010701

• Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer.

  European journal of cancer (Oxford, England : 1990) 20010601

• Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010601

• Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.

  Seminars in oncology 20010601

• Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.

  Seminars in oncology 20010601

• Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer.

  Seminars in oncology 20010601

• In vitro activity of vinorelbine on human leukemia cells.

  Journal of chemotherapy (Florence, Italy) 20010601

• Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010601

• Phase II study of vinorelbine in patients with androgen-independent prostate cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010601

• Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.

  Breast cancer research and treatment 20010601

• Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010501

• Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.

  European journal of cancer (Oxford, England : 1990) 20010501

• [Non-small-cell lung cancer (NSCLC) in an elderly patient--a case of squamous cell carcinoma successfully treated with chemotherapy using vinorelbine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010501

• Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry.

  Journal of chromatography. B, Biomedical sciences and applications 20010405

• Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinoma.

  Gynecologic oncology 20010401

• Preoperative chemotherapy for lung cancer does not increase surgical morbidity.

  The Annals of thoracic surgery 20010401

• Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer.

  Seminars in oncology 20010401

• Possible drug interaction between itraconazole and vinorelbine tartrate leading to death after one dose of chemotherapy.

  Annals of internal medicine 20010306

• Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.

  Cytometry 20010301

• Concurrent administration of vinorelbine with human recombinant granulocyte-macrocyte stimulating factor.

  International journal of oncology 20010301

• Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.

  Haematologica 20010301

• [A case of recurrent lung cancer successfully treated with vinorelbine and cisplatin].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010301

• Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer.

  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20010301

• Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.

  European journal of cancer (Oxford, England : 1990) 20010301

• Prevention of vinorelbine phlebitis with cimetidine. A two-step design study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20010301

• Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine.

  Cancer chemotherapy and pharmacology 20010301

• [Cisplatin and vinorelbine therapy of previously treated advanced breast cancer (preliminary studies)].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20010301

• Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.

  Cancer 20010215

• Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201

• Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies.

  Cancer 20010201

• Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel.

  American journal of clinical oncology 20010201

• Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20010201

• [Induction chemotherapy (cisplatin + vinorelbine) is found to be markedly effective for squamous cell lung carcinoma with sarcoidosis--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010201

• [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010201

• Treatment of advanced breast cancer with gemcitabine and vinorelbine.

  Oncology (Williston Park, N.Y.) 20010201

• Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.

  Seminars in oncology 20010201

• Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model.

  British journal of cancer 20010101

• Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.

  Lung cancer (Amsterdam, Netherlands) 20010101

• Phase I study of paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancer.

  Lung cancer (Amsterdam, Netherlands) 20010101

• New directions in the treatment of non-small cell lung cancer: an overview.

  The oncologist 20010101

• The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.

  The oncologist 20010101

• Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

  The oncologist 20010101

• Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study.

  The oncologist 20010101

• Options in advanced non-small cell lung cancer: a review and report on a phase II study of vinorelbine plus gemcitabine.

  The oncologist 20010101

• Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.

  The oncologist 20010101

• Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.

  The oncologist 20010101

• Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.

  Oncology reports 20010101

• Chemoradiation in locally advanced non-small cell lung cancer.

  Cancer treatment and research 20010101

• Lung cancer: therapeutic options for stage IV and recurrent NSCLC.

  Cancer treatment and research 20010101

• Treatment of extensive stage small cell lung cancer.

  Cancer treatment and research 20010101

• Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010101

• A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer.

  Current medical research and opinion 20010101

• Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.

  Oncology 20010101

• Correspondence re: Cicchetti S, Jemec B, Gault DT: two case reports of vinorelbine extravasation: management and review of the literature. Tumori, 86: 289-292, 2000.

  Tumori 20010101

• Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study.

  Oncology reports 20010101

• Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study.

  The oncologist 20010101

• Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.

  Cancer investigation 20010101

• Spontaneous erections in a patient with erectile dysfunction after palliative chemotherapy for non-small cell lung cancer.

  Urologia internationalis 20010101

• Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer.

  The oncologist 20010101

• Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.

  Oncology 20010101

• Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine.

  Oncology 20010101

• New combinations with Herceptin in metastatic breast cancer.

  Oncology 20010101

• An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

  Anticancer research 20010101

• Cost effectiveness of treatment options in advanced breast cancer in the UK.

  PharmacoEconomics 20010101

• Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus.

  Tumori 20010101

• Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.

  Medical oncology (Northwood, London, England) 20010101

• [Results of phase II clinical trial of cycloplatam in refractory solid tumors].

  Voprosy onkologii 20010101

• First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.

  Anticancer research 20010101

• Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.

  Anticancer research 20010101

• A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

  Health technology assessment (Winchester, England) 20010101

• Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.

  International journal of clinical pharmacology research 20010101

• A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma.

  Cancer 20000201

• [Adverse (cardio-)vascular effects of vinorelbine in non-small-cell bronchial carcinoma].

  Pneumologie (Stuttgart, Germany) 20000201

• A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.

  Annals of oncology : official journal of the European Society for Medical Oncology 20000101

• Second-line chemotherapy with paclitaxel, cisplatin and gemcitabine in pre-treated sensitive cisplatin-based patients with advanced non-small cell lung cancer.

  Anticancer research 20000101

• First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.

  American journal of clinical oncology 19991201

• Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.

  Journal of the National Cancer Institute 19991020

• Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative Group.

  Cancer 19991015

• Acquired protein C deficiency following cisplatinum-navelbine administration for locally advanced breast cancer. Case report.

  European journal of gynaecological oncology 19990101

• Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy.

  The Annals of pharmacotherapy 19981201

• [Acute pain due to vinorelbine].

  Revista clinica espanola 19980801

• A case of ototoxicity in a patient with metastatic carcinoma of the breast treated with paclitaxel and vinorelbine.

  European journal of cancer (Oxford, England : 1990) 19980601

• [Phlebitis after vinorelbine].

  Schweizerische medizinische Wochenschrift 19980227

• Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancer.

  American journal of clinical oncology 19970801

• Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.

  American journal of clinical oncology 19970801

• Vinorelbine chemotherapy in non small cell lung cancer: experience in elderly patients.

  Journal of chemotherapy (Florence, Italy) 19970801

• Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma.

  American journal of clinical oncology 19961201

• Acute tumor pain in patients with head and neck cancer treated with vinorelbine.

  Journal of the National Cancer Institute 19961106

• Severe neurotoxicity from vinorelbine-paclitaxel combinations.

  Journal of the National Cancer Institute 19960807

• Myocardial infarction associated with vinorelbine (Navelbine).

  European journal of cancer (Oxford, England : 1990) 19960801

• Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.

  Seminars in oncology 19960401

• Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19960101

• Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.

  Cancer chemotherapy and pharmacology 19960101

• A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer.

  British journal of cancer 19951101

• Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine).

  Oncology nursing forum 19950501

• Combined doxorubicin/vinorelbine (Navelbine) therapy in the treatment of advanced breast cancer.

  Seminars in oncology 19950401

• A phase II trial of vinorelbine and thiotepa in metastatic breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 19950201

• Myocardial ischemia and infarction associated with vinorelbine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19950201

• Pain at tumor site after vinorelbine injection: description of an unexpected side effect.

  Tumori 19950101

• Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19941001

• Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940501

• Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II study.

  Investigational new drugs 19940101

• [Myocardial infarction and vinorelbine. Report of a case].

  Revue des maladies respiratoires 19910101